Eli Lilly nears $2 bln deal for cancer biotech Kelonia, WSJ reports
Entity Intersection Graph
No entity connections available yet for this article.
More from USA
- A crowd scientist is helping the Boston Marathon manage a growing field of 30,000-plus runners
- Frank Marshall Says ESPN Pulled His Doc ‘Rachel, Breathe’ “An Hour Before Broadcast” Over Rights Disagreement
- China leaves lending benchmarks unchanged for 11th month in April
- Factbox-From airlines to banks: Australian, New Zealand firms feel heat of Gulf crisis
- UFL Trade Blockbuster: Stallions, Storm and Kings, Defenders Swap Stars
- Surging record-high US stocks to wade deeper into earnings season
News from Other Countries
🇬🇧 United Kingdom
- Frustration, apathy and hope: Birmingham divided as extraordinary election looms
- India has splurged billions on metro trains. But where are the commuters?
- Why your recycled clothes could end up in this South American desert